by epivax3 | Sep 7, 2010 | News
EpiVax, a paradigm-shifting biotechnology company, takes the road this fall to share news about Tregitope – the small peptides contained in IgG that trigger regulatory T cells – and other cutting-edge science and technology with scientific colleagues. Starting in...
by epivax3 | Sep 7, 2010 | News
The following abstract was selected for presentation at the American Transplant Congress in a plenary session: Ex Vivo Expansion of Human Antigen-Specific Natural Tregs Using IgG Fc Derived Peptides (Tregitopes) Francesca D’Addio, Olaf Boenisch, Toshiko...
by epivax3 | May 18, 2010 | News
Providence-based biotechnology company selected from more than 100 global research initiatives aimed at impacting drug development Tregitope Innovation Award Press Release (PDF) May 18, 2010 (Providence, RI; San Francisco, CA)—At the American Association of...
by epivax3 | May 4, 2010 | News
From projo.com Free clinic finds ‘real’ home 01:00 AM EDT on Tuesday, May 4, 2010 By Philip Marcelo Journal Staff Writer Dr. Anne De Groot conducts a tour to show construction progress on the future site of the clinic on Valley Street in Olneyville. The Providence...
by epivax3 | May 1, 2010 | News
Knowledge District: Five scientists whose cutting-edge research is giving the historic jewelry district a new name With the rerouting of I-195 in Providence and the dismantling of the decrepit old highway that cut off one corner of the city, the overlooked Jewelry...
